Skandinaviska Enskilda Banken AB (publ)
Institutional investor · Portfolio as of Q4 2018
Top Holdings787 positions
Pfizer Inc | 8M | $350.9M | 3.1% | $28.59 | 0.00% | 1 qtr | First report 0 |
Intel Corp | 6.7M | $314.9M | 2.8% | $40.39 | 0.00% | 1 qtr | First report 0 |
Gilead Sciences Inc | 4.9M | $303.4M | 2.7% | $46.93 | 0.00% | 1 qtr | First report 0 |
HP Inc | 12.9M | $264.6M | 2.4% | $15.50 | 0.00% | 1 qtr | First report 0 |
CVS Health Corp | 3.8M | $246.4M | 2.2% | $51.03 | 0.00% | 1 qtr | First report 0 |
Kohl's Corp | 3.7M | $245.3M | 2.2% | $44.13 | 0.00% | 1 qtr | First report 0 |
Verizon Communications Inc | 4.1M | $231.3M | 2.1% | $37.01 | 0.00% | 1 qtr | First report 0 |
Target Corp | 3.3M | $217.8M | 2.0% | $53.18 | 0.00% | 1 qtr | First report 0 |
Macy's Inc | 6.8M | $202.8M | 1.8% | $22.38 | 0.00% | 1 qtr | First report 0 |
Cummins Inc | 1.5M | $198.4M | 1.8% | $110.00 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp | 1.9M | $193.9M | 1.7% | $94.43 | 0.00% | 1 qtr | First report 0 |
Aflac Inc | 4M | $184M | 1.6% | $38.13 | 0.00% | 1 qtr | First report 0 |
Apple Inc | 1.2M | $183.2M | 1.6% | $37.39 | 0.00% | 1 qtr | First report 0 |
LyondellBasell Industries NV | 2.2M | $181M | 1.6% | $52.67 | +13.97% | 1 qtr | First report 0 |
Johnson & Johnson | 1.4M | $179.5M | 1.6% | $104.33 | 0.00% | 1 qtr | First report 0 |
Annaly Capital Management Inc | 17.6M | $173.2M | 1.6% | — | — | — | First report 0 |
Best Buy Co Inc | 3M | $160.9M | 1.4% | $39.27 | 0.00% | 1 qtr | First report 0 |
CenterPoint Energy Inc | 5.6M | $158.3M | 1.4% | $22.86 | 0.00% | 1 qtr | First report 0 |
SEAGATE TECHNOLOGY PLC | 4M | $154.5M | 1.4% | $29.39 | +2564.17% | 1 qtr | First report 0 |
Canadian Imperial Bank of Comm | 2M | $148.9M | 1.3% | $26.23 | 0.00% | 1 qtr | First report 0 |
Skandinaviska Enskilda Banken AB (publ) manages $11.2B across 787 positions as of Q4 2018. Top holdings: PFE (3.1%), INTC (2.8%), GILD (2.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 787 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $11.2B across 787 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR